1M17

Epidermal Growth Factor Receptor tyrosine kinase domain with 4-anilinoquinazoline inhibitor erlotinib

Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.60 Å
  • R-Value Free: 0.295 
  • R-Value Work: 0.251 
  • R-Value Observed: 0.251 

wwPDB Validation   3D Report Full Report


This is version 1.2 of the entry. See complete history. 


Literature

Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor.

Stamos, J., Sliwkowski, M.X., Eigenbrot, C.

(2002) J Biol Chem 277: 46265-46272

  • DOI: 10.1074/jbc.M207135200
  • Primary Citation of Related Structures:  
    1M14, 1M17

  • PubMed Abstract: 

    • The crystal structure of the kinase domain from the epidermal growth factor receptor (EGFRK) including forty amino acids from the carboxyl-terminal tail has been determined to 2.6-A resolution, both with and without an EGFRK-specific inhibitor currently in Phase III clinical trials as an anti-cancer agent, erlotinib (OSI-774, CP-358,774, Tarceva(TM)) ...

    The crystal structure of the kinase domain from the epidermal growth factor receptor (EGFRK) including forty amino acids from the carboxyl-terminal tail has been determined to 2.6-A resolution, both with and without an EGFRK-specific inhibitor currently in Phase III clinical trials as an anti-cancer agent, erlotinib (OSI-774, CP-358,774, Tarceva(TM)). The EGFR family members are distinguished from all other known receptor tyrosine kinases in possessing constitutive kinase activity without a phosphorylation event within their kinase domains. Despite its lack of phosphorylation, we find that the EGFRK activation loop adopts a conformation similar to that of the phosphorylated active form of the kinase domain from the insulin receptor. Surprisingly, key residues of a putative dimerization motif lying between the EGFRK domain and carboxyl-terminal substrate docking sites are found in close contact with the kinase domain. Significant intermolecular contacts involving the carboxyl-terminal tail are discussed with respect to receptor oligomerization.

    Organizational Affiliation: 

    Department of Protein Engineering, Genentech, Inc., South San Francisco, California 94080, USA.



Macromolecules
Find similar proteins by: 
(by identity cutoff)  |  Structure
Entity ID: 1
MoleculeChainsSequence LengthOrganismDetailsImage
epidermal growth factor receptorA333Homo sapiensMutation(s): 0 
Gene Names: EGFR, ERBB, ERBB1, HER1
EC: 2.7.1.112 (PDB Primary Data), 2.7.10.1 (UniProt)
Find proteins for P00533 (Homo sapiens)
Explore P00533 
Go to UniProtKB:  P00533
NIH Common Fund Data Resources
PHAROS:  P00533
GTEx:  ENSG00000146648
Protein Feature View
Expand
  • Reference Sequence
Small Molecules
Ligands 1 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
AQ4
Query on AQ4
Download Ideal Coordinates CCD File 
 B [auth A][6,7-BIS(2-METHOXY-ETHOXY)QUINAZOLINE-4-YL]-(3-ETHYNYLPHENYL)AMINE
C22 H23 N3 O4
AAKJLRGGTJKAMG-UHFFFAOYSA-N		 Ligand Interaction
External Ligand Annotations 
IDBinding Affinity (Sequence Identity %)
AQ4Kd:  0.8500000238418579   nM  BindingDB
AQ4IC50:  1   nM  BindingDB
AQ4IC50:  170   nM  BindingDB
AQ4Kd:  0.9700000286102295   nM  BindingDB
AQ4IC50:  200   nM  BindingDB
AQ4IC50:  6.300000190734863   nM  BindingDB
AQ4IC50:  0.5   nM  BindingDB
AQ4IC50:  160   nM  BindingDB
AQ4Kd:  1.2000000476837158   nM  BindingDB
AQ4Ki:  123   nM  BindingDB
AQ4Ki:  136   nM  BindingDB
AQ4IC50:  0.029999999329447746   nM  BindingDB
AQ4Ki:  95   nM  BindingDB
AQ4IC50:  3   nM  BindingDB
AQ4Kd:  1.600000023841858   nM  BindingDB
AQ4Ki:  0.10000000149011612   nM  BindingDB
AQ4Kd:  970   nM  BindingDB
AQ4Ki:  45   nM  BindingDB
AQ4IC50:  2   nM  BindingDB
AQ4IC50:  0.4000000059604645   nM  BindingDB
AQ4Kd:  0.6700000166893005   nM  BindingDB
AQ4IC50:  7.599999904632568   nM  BindingDB
AQ4IC50:  19.299999237060547   nM  BindingDB
AQ4IC50:  260   nM  BindingDB
AQ4IC50:  20.299999237060547   nM  BindingDB
AQ4IC50:  15   nM  BindingDB
AQ4IC50:  16   nM  BindingDB
AQ4IC50:  0.20000000298023224   nM  BindingDB
AQ4IC50:  0.6000000238418579   nM  BindingDB
AQ4IC50:  19   nM  BindingDB
AQ4IC50:  20   nM  BindingDB
AQ4IC50:  11   nM  BindingDB
AQ4Kd:  1   nM  BindingDB
AQ4IC50:  2.5999999046325684   nM  BindingDB
AQ4Kd:  190   nM  BindingDB
AQ4IC50:  8   nM  BindingDB
AQ4IC50:  3.5999999046325684   nM  BindingDB
AQ4Kd:  0.4699999988079071   nM  BindingDB
AQ4IC50:  1.2000000476837158   nM  BindingDB
AQ4IC50:  10   nM  BindingDB
AQ4IC50:  3.0999999046325684   nM  BindingDB
AQ4Kd:  1.399999976158142   nM  BindingDB
AQ4Kd:  140   nM  BindingDB
AQ4IC50:  60   nM  BindingDB
AQ4IC50:  68   nM  BindingDB
AQ4IC50:  70   nM  BindingDB
AQ4IC50:  73   nM  BindingDB
AQ4IC50:  77   nM  BindingDB
AQ4IC50:  80   nM  BindingDB
AQ4IC50:  48   nM  BindingDB
AQ4IC50:  51   nM  BindingDB
AQ4Kd:  0.47999998927116394   nM  BindingDB
AQ4IC50:  0.699999988079071   nM  BindingDB
AQ4IC50:  30   nM  BindingDB
AQ4IC50:  32   nM  BindingDB
AQ4IC50:  5.900000095367432   nM  BindingDB
AQ4IC50:  34   nM  BindingDB
AQ4IC50:  35   nM  BindingDB
AQ4Kd:  0.5199999809265137   nM  BindingDB
AQ4Kd:  0.3499999940395355   nM  BindingDB
AQ4IC50:  23   nM  BindingDB
AQ4Ki:  0.30000001192092896   nM  BindingDB
AQ4IC50:  1.2999999523162842   nM  BindingDB
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.60 Å
  • R-Value Free: 0.295 
  • R-Value Work: 0.251 
  • R-Value Observed: 0.251 
  • Space Group: I 2 3
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 147.8α = 90
b = 147.8β = 90
c = 147.8γ = 90
Software Package:
Software NamePurpose
DENZOdata reduction
TRUNCATEdata reduction
AMoREphasing
X-PLORrefinement
CCP4data scaling

Structure Validation

View Full Validation Report


View more in-depth experimental data

Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2002-09-04
    Type: Initial release
  • Version 1.1: 2008-04-28
    Changes: Version format compliance
  • Version 1.2: 2011-07-13
    Changes: Version format compliance